Stockchase Opinions

Jim Cramer - Mad Money Seres Therapeutics MCRB-Q DON'T BUY Jul 24, 2023

Poorly run, and it's losing money hand over fist.

$4.390

Stock price when the opinion was issued

biotechnology pharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.